Khalid Sossey-Alaoui

13PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersFree radical chemistryCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 01, 2026
The small molecule inhibitor SU056-mediated targeting of YB1 inhibits the Rb pathway in triple negative breast cancer tumors.

|Jul 29, 2026
Nuclear translocation of phosphorylated YB-1 via small extracellular vesicles contributes to the malignant phenotype of triple negative breast cancer.

|Jul 11, 2025
Role of Kindlin-2-Expressing Extracellular Vesicles in the Invasiveness of Triple Negative Breast Cancer Tumor Cells.

Neelum Aziz Yousafzai, Mark F Santos, Yeaji Kim

|Feb 07, 2025
Kindlin-2-Mediated Hematopoiesis Remodeling Regulates Triple-Negative Breast Cancer Immune Evasion.

Wei Wang, Rahul Chaudhary, Justin Szpendyk

|Sep 19, 2024
Kindlin-2 regulates the oncogenic activities of integrins and TGF-β in triple-negative breast cancer progression and metastasis.

Neelum Aziz Yousafzai, Lamyae El Khalki, Wei Wang

|Jul 18, 2024
Role of WAVE3 as an actin binding protein in the pathology of triple negative breast cancer.

Kruyanshi Master, Lamyae El Khalki, Mekki Bayachou

Pageof 3

Frequent Collaborators

6 joint publications

Wei Wang

2 joint publications

Aurelio Lorico

2 joint publications

Mark F Santos

2 joint publications

Ricky Chan